Skip to content

Everolimus

Everolimus (Afinitor) appears in one listed tablet product, Afinitor.

Afinitor

Renal Cell Carcinoma, Breast Cancer

5mg

Developed to target cancer cells to support tumour growth suppression.

From$43.64/ tabletView

What is Everolimus used for?

One listed use is Renal Cell Carcinoma. Another treatment context is Breast Cancer. The product information also identifies Neuroendocrine Tumours. Related medicines appear within Oncology Support.

Important safety information for Everolimus

Information about Everolimus on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.